Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Capecitabine market 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Indication trends
2.1.4 Synthesis type trends
2.1.5 Mode trends
Chapter 3 Capecitabine Market Insights
3.1 Industry ecosystem analysis
3.2 COVID-19 impact analysis
3.3 Regulatory landscape
3.3.1 U.S.
3.3.2 Europe
3.4 Pricing analysis, by region (USD Million)
3.4.1 Selling price in USD per kg
3.5 Innovation & sustainability
3.6 Industry impact forces
3.6.1 Growth drivers
3.6.1.1 Increasing incidences of cancer
3.6.1.2 Surging demand for generics
3.6.1.3 Rising drug related research and development activities
3.6.2 Industry pitfalls & challenges
3.6.2.1 High manufacturing cost
3.7 Growth potential analysis
3.7.1 By indication
3.7.2 By synthesis type
3.7.3 By mode
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Strategic outlook matrix, 2022
4.3 Company market share analysis
4.3.1 Global
4.3.2 North America
4.3.3 Europe
4.3.4 Asia Pacific
4.4 Production capacity
4.5 List of top 20 end consumers with contact details/email id
4.6 Competitive positioning matrix, 2022
Chapter 5 Capecitabine Market Estimates and Forecast, By Indication, 2018 - 2032 (USD Million)
5.1 Key trends, by indication
5.2 Breast cancer
5.3 Colorectal cancer
5.4 Gastric cancer
5.5 Pancreatic cancer
5.6 Other indications
Chapter 6 Capecitabine Market Estimates and Forecast, By Synthesis Type, 2018 - 2032 (USD Million)
6.1 Key trends, by synthesis type
6.2 Chemical based API
6.3 Biological API
6.4 Highly potent API (HPAPI)
Chapter 7 Capecitabine Market Estimates and Forecast, By Mode, 2018 - 2032 (USD Million)
7.1 Key trends, by mode
7.2 In-house manufacturing
7.3 Contract manufacturing
Chapter 8 Capecitabine Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Russia
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Malaysia
8.4.7 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Sun Pharmaceutical Industries Ltd
9.2 Shilpa Medicare limited
9.3 Atom Pharma
9.4 Global Calcium
9.5 LGM Pharma
9.6 Dr. Reddy’s Laboratories Ltd
9.7 Cipla Ltd
9.8 Zeon Pharma
9.9 Avanscure Lifesciences Pvt Ltd
9.10 Hepartex
